Enfusion — Merger or Acquisition (January 2025)
83 slides from Enfusion's merger presentation, Jan 13, 2025
Slide 1: Filed by Clearwater Analytics Holdings pursuant to Rule 425
Filed by Clearwater Analytics Holdings, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Enfusion, Inc. Commission File No.: 001-40949 1. The following presentation was published by
Slide 2: Forward-looking statements
This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our managem
Slide 3: Financial Information and NPS
Financial Information and NPS. Net Promoter Score ( NPS ) refers to our net promoter score, which can range from a low of negative 100 to a high of positive 100, that we use to gauge customer satisfaction. NPS benchmarks can vary significantly by industry, but a score greater than zero represents a
Slide 4: Agenda
Agenda: 1. Continued Momentum in Q4 2024 2. Enfusion Acquisition Overview 3. Strategic Rationale
Slide 5: Continued Momentum in Q4 2024
@) Continued Momentum in Q4 2024
Slide 6: Revenue history 2016-2023
($ in millions) 2016 2017 2018 2019 2020 2021 2022 2023
Slide 7: Note on financial metrics
Note: • All financial metrics are as of September 30, 2024, unless noted otherwise.
Slide 8: Reaffirming Q4 guidance
Reaffirming Q4 guidance We are comfortable we will meet and exceed our stated guidance for both Q4 and full year 2024. Fourth Quarter and Full Year 2024 Guidance Fourth Quarter 2024 Full Year 2024 Revenue $120.2 million $445.5 million Year-over-Year Growth % ~21% ~21% Adjusted EBITDA $38.5 million $
Slide 9: Enfusion Acquisition Overview
@) Enfusion Acquisition Overview
Slide 10: Enfusion overview
• Enfusion's investment management software-as-a-service platform has wide acceptance as the disruptive leader in the hedge fund and asset management markets. ~ • Its comprehensive platform includes market leading functionality related to IBOR, portfolio management, order management and pre-trade co
Slide 11: Transaction Overview
Transaction Summary Deal Collar Timing Transaction Overview + Purchase price of $11.25 per share; approximately $1.5 billion + $11.25 per share consists of $5.85 per share in cash and $5.40 per share in Class A Common Stock + Represents a 13% premium over the January 10, 2025 closing price of Enfusi
Slide 12: Our Long-Term Goals Remain Unchanged
Our Long-Term Goals Remain Unchanged: ~
Slide 13: Strategic Rationale
@) Strategic Rationale
Slide 14: Clearwater's Mission
Clearwater’s Mission Be the world’s most trusted and comprehensive technology platform that simplifies the entire investment lifecycle... and eventually revolutionize the world of investing. CLEARWATER ANALYTICS
Slide 15: Strategic rationale for the combination
Today’s announcement is about creating a future where our clients benefit from the synergy of two highly complementary, innovative software leaders, paving the way for a unified, cloud-native front-to-back platform that’s primed to serve institutional investors like never before. We expect this comb
Slide 16: Front-to-Back platform for the entire investment lifecycle
0 Accelerate our goal of building a Front-to-Back platform for the entire investment lifecycle e Sy» Xs : . 4 a ad Ooty Se 2 SS SS 6 i oe PSN SEE ES | Se Hes soy oo oe ae eae s & or es ‘6 CRCICROROICICIOM TT i i Mt I Sx I BiCRae; eee eeoaeoa@oddO (9CG0CAC0 @GCGCA00 e@@e@°8@ Front-to-back platform fo
Slide 17: Improves right to win in Asset Management
Meaningfully improves our right to win in the Asset Management industry Total global market opportunity build ($bn) $4bn out of the current 7 7 3 Core TAM of $5.9bn in 59 =z Asset Management ‘Core markets: Adjacent markets’ Clearwater Prism APACE Global market Core markets - Detailed build up Combin
Slide 18: Offer Enfusion's IBOR / PMS / OMS to Clearwater clients
Offer Enfusion’s IBOR / PMS / OMS to Clearwater clients Furthers our 1 bp to 4 bps journey Abps Total Investment lanagement Technology Spend 3bps Room for Future Growth CLEARWATER Nn NALYTICS Areas for which we are continuing to build transformative solutions: Order Management Portfolio Management P
Slide 19: Hedge Fund industry expands TAM
Build on the leadership position in the Hedge Fund industry, expanding our TAM $5.9bn eee The addition of Hedge Fund industry is expected to increase CWAN’s core TAM by $1.9b $7.8bn CLEARWATER Nn NALYTICS
Slide 20: Greater presence in Europe and Asia
Use Enfusion’s greater presence in Europe and Asia to drive faster adoption of the CWAN platform ~50% of our TAM is in Europe and Asia and we currently derive only 18% of our revenue from those geographies % Revenue from BBE united states Rest of world CLEARWATER 20 AN ALYTICS
Slide 21: Financially compelling transaction
6 - Enfusion Standalone + High-quality recurring revenue model supported by sticky client base and further avenues for growth * Strong margin profile and scalable business with operating leverage * Cash flow generative business with additional opportunities for efficiency ~ Re-accelerate Growth --..
Slide 22: Clearwater Analytics
CLEARWATER ANALYTICS
Slide 23: CWAN Townhall January 13
2. The following slides were presented to employees of Clearwater Analytics Holdings, Inc. at a townhall meeting on January 13, 2025. CWAN Townhall January 13
Slide 24: Safe Harbor
Safe Harbor This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Clearwater Analytics Holdings, Inc.'s ( Clearwater ) and Enfusion Inc.'s ( Enfusio
Slide 25: Financial Information and NPS
Financial Information and NPS. Net Promoter Score ( NPS ) refers to our net promoter score, which can range from a low of negative 100 to a high of positive 100, that we use to gauge customer satisfaction. NPS benchmarks can vary significantly by industry, but a score greater than zero represents a
Slide 26: We have already come a very long way as a company
We have already come a very long way as a company There is so much to be proud of
Slide 27: Slide 27
Slide 28: Great growth and great profitability
Great growth and great profitability Generally regarded as very difficult to achieve $445.5* 21% YoY $281.8 $368.2 76.5% 21% YoY $253.8 78% $228.0 $303.4 $325.321% 75.1% YoY 20% YoY $190.6 $252.0 75.6% 24% YoY $152.7 $203.2 75.1% 21% YoY $168.0 $122.7 73.1% 2019 2020 2021 2022 2023 2024 2019 2020 20
Slide 29: Investments in growth
Investments in growth Continued commitment to R&D, Operations, GTM and Enabling functions Our Investment in Each Functional Area has Increased Meaningfully 2.2x 4-year growth in Sales & Marketing Investment 2x 4-year growth in Operations Investment 2.7x 4-year growth in R&D investment S&M Operations
Slide 30: Market recognizes our potential
And the market recognizes our potential #5 revenue multiple among 66 SaaS at end-Q4 2024 clearwateranalytics.com • 8
Slide 31: Our ambition must continue to evolve and grow
Our ambition for the company must continue to evolve and grow
Slide 32: Vision for the Future
Entire Investment Management Life cycle … Vision for the Future Where we started … Be the world’s most trusted and comprehensive technology platform that simplifies Be the world’s most trusted and comprehensive technology the entire investment lifecycle... platform for investment accounting and anal
Slide 33: Entire investment management life cycle vision
Entire Investment Management Life cycle Vision for the Future Be the world’s most trusted and comprehensive technology platform that simplifies the entire investment lifecycle... ➢Alternatives (LPs, MLs, Derivatives) and eventually revolutionize the world ➢Funds (Stable Value, Pooled, ULF) of invest
Slide 34: Clearwater Analytics + Enfusion
Clearwater Analytics + Enfusion Shaping the Future of Investment Management.
Slide 35: Better Together
Better Together
Slide 36: Two complementary, innovative software leaders
Bringing two very similar, complementary and innovative software leaders together clearwateranalytics.com • 14 clearwateranalytics.com • 14
Slide 37: Modern, Cloud-Native, Single-Instance Multi-Tenant Platform
Modern, Cloud-Native, Single-Instance Multi-Tenant Platform
Slide 38: Top Line Growth YoY
Clearwater’s and Enfusion’s Top Line Growth YoY $445.5* ENFN’s and CWAN’s IPO $368.2 $303.4 $252 $203.2 $201.5* $174.5 $168 $150.4 $111.7 $79.6 $59 2019 2020 2021 2022 2023 2024 ENFN CWAN Expon. (ENFN) Expon. (CWAN) $ in millions *Estimated for 2024
Slide 39: Overall Strategic Rationale
Overall Strategic Rationale Today’s announcement is about creating a future where our clients benefit from the synergy of two highly complementary, innovative software leaders, paving the way for a unified, cloud-native front-to-back platform We expect this combination to do the following: 1. Accele
Slide 40: Front-to-Back platform for the entire investment lifecycle
Accelerate our goal of building a Front-to-Back platform for the entire 1 investment lifecycle Middle & Back Office Front Office Platform Front-to-back platform for the entire investment lifecycle At Market Above Market 18 Limited Capability No Capability
Slide 41: Expansion into the Asset Management industry
Expansion into the Asset Management industry 2 $4 B out of the current Core TAM of $5.9 B in Asset Management 19
Slide 42: Offer Enfusion's IBOR / PMS / OMS to Clearwater clients
Offer Enfusion’s IBOR/ PMS / OMS 3 to Clearwater clients Solutions Clearwater doesn’t fully address include: 1. Order Management 2. Portfolio Management 3. Pre-Trade risk and compliance 4. Front end of LPs 5. Mortgages 20
Slide 43: Leadership position in the Hedge Fund industry
Build on Enfusion’s leadership position in the Hedge Fund industry, 4 where Clearwater does not participate today $7.8bn ~$1.9bn $5.9bn $4.0bn $4.0bn The addition of Hedge Fund industry increases CWAN’s core TAM by $1.9bn Hedge Fund Asset Managers $1.6bn $1.6bn Insurance Corporations $0.3bn $0.3bn 2
Slide 44: Presence in Europe and Asia
Use Enfusion’s greater presence in Europe and Asia to drive faster 5 adoption of the CWAN platform 18% ~50% of our TAM is in Europe and 38% Asia and we currently derive only 18% of our revenue from those ENFN CWAN geographies 62% 82% % Revenue from United States Rest of World 22
Slide 45: Special Guests Joining Us Today
We Have Special Guests Joining Us Today! Oleg Movchan Neal Pawar CEO, Enfusion COO, Enfusion clearwateranalytics.com • 23
Slide 46: Enfusion
Enfusion CONFIDENTIAL
Slide 47: Disclaimer
Disclaimer This Confidential Information Memorandum (this “Presentation”) has been prepared for discussion purposes only in connection with your consideration of a potential transaction (a “Transaction”) with Enfusion, Inc. and/or its affiliates (collectively, the “Company”). This Presentation and a
Slide 48: Enfusion's Mission
ENFUSION’S MISSION To power all investment workflows with our unparalleled technology, relentless innovation, and dedicated focus on clients. PROPRIETARY AND P C R O ON PF R ID IEE TN AT RIY AL © ©2 20 02 24 5 E EN NF FU US SIIO ON N.. A AL LL L R RIIG GH HT TS S R RE ES SE ER RV VE ED D.. 26
Slide 49: Enfusion Is An Exceptional Business Today
Enfusion Is An Exceptional Business Today… $1.3T 900+ NAV of Total Clients Enfusion Clients Undisputed Leader in Investment Management Technology at Scale 120+ 30% Asset Manager & ARR From $500K+ Proven Ability to Develop Fit-for-Purpose Solutions Owner Clients ACV Clients 80%+ 40%+ Uniquely Positio
Slide 50: Global Workforce with Scale Across Diverse Regions
Global Workforce with Scale Across Diverse Regions FTEs by Geography Region FTE Counts Americas 362 EMEA 83 Dublin APAC 102 India 588 Chicago New London York Hong Kong Total 1135 Mumbai Bangalore Singapore Sydney PROPRIETARY AND CONFIDENTIAL ©2025 ENFUSION. ALL RIGHTS RESERVED. 28
Slide 51: Connectivity Around the Globe
…With Connectivity Around the Globe Americas EMEA APAC 1 1 1 480+ Clients 160+ Clients 240+ Clients (~55% of Total) (~16% of Total) (~27% of Total) 2 2 2 $130M+ ARR $35M+ ARR $45M+ ARR (~61% of Total) (~18% of Total) (~22% of Total) PROPRIETARY AND CONFIDENTIAL ©2025 ENFUSION. ALL RIGHTS RESERVED. 2
Slide 52: Clients Across the Investment Management Industry
We Serve Clients Across the Investment Management Industry… Equity Hedge Fund Managers Non-Equity Hedge Fund Managers Asset Managers and Asset Owners ✓ Long Only Strategies✓ Pensions ✓ Credit / Distressed✓ Multi-Manager ✓ Market Neutral✓ Short Only ✓ Liquid Alternatives ✓ Endowments ✓ Event Driven✓
Slide 53: Platform by the Numbers: A Story of Scale
Enfusion’s Platform by the Numbers: A Story of Scale NAV All Orders & Fills All Trade & Allocation Events $1.3 Trillion 168 million 478 million 29% YoY Growth 90.95% Growth from 2022 55.74% Growth from 2022 12 Month Uptime Percentage Active Positions Active Funds 99.995% 1.4 million 9,540 Up from 99
Slide 54: What we can do together
We are excited about what we can do together! Company Business Unit(s) or Product(s) Forecast Growth 2024 (Based on Opimas Estimates) Clearwater Analytics Investment Accounting Software 22% Enfusion Investment Management Software 15% Morningstar Direct, Workstation 11% 10% Deutsche Boerse (Simcorp)
Slide 55: Next Steps
Next Steps 1 3 4 2 Continue the deal FAQs and improve our Actively manage the Deal close and process through close – understanding of each reactions from clients & integration begins but we remain two partners other via joint separate companies integration planning until then teams This should be a
Slide 56: Enfusion Employee Townhall
3. The following slides were presented by Sandeep Sahai, Chief Executive Officer of Clearwater Analytics Holdings, Inc., to employees of Enfusion, Inc. at a townhall meeting on January 13, 2025. Enfusion Employee Townhall
Slide 57: Safe Harbor
Safe Harbor This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Clearwater Analytics Holdings, Inc.'s ( Clearwater ) and Enfusion Inc.'s ( Enfusio
Slide 58: Financial Information and NPS
Financial Information and NPS. Net Promoter Score ( NPS ) refers to our net promoter score, which can range from a low of negative 100 to a high of positive 100, that we use to gauge customer satisfaction. NPS benchmarks can vary significantly by industry, but a score greater than zero represents a
Slide 59: Enfusion + Clearwater Analytics
Enfusion + Clearwater Analytics Shaping the Future of Investment Management.
Slide 60: Clearwater's Mission
Clearwater’s Mission Be the world’s most trusted and comprehensive technology platform that simplifies the entire investment lifecycle... and eventually revolutionize the world of investing.
Slide 61: Key to Sustained Success
Key to Sustained Success Outstanding and Engaged Team Outstanding & Engaged Team Tech Innovation Strong & Financials Platform Client Delight clearwateranalytics.com • 6
Slide 62: Consistent Top Line Growth
Success starts with Consistent Top Line Growth $445.5* 21% YoY $368.2 21% YoY $303.4 $325.3 20% YoY 21% YoY $252.0 Q3 2024 Revenue 24% YoY $203.2 Grew 22% YoY 21% YoY $168.0 2019 2020 2021 2022 2023 2024 to Q3 YTD 7 *Previously provided CWAN Revenue - $ in millions Q4 Guidance
Slide 63: Invest to Grow
Invest to Grow Our Investment in Each Functional Area has Increased Meaningfully 2.2x 4-year growth in Sales & Marketing Investment 2x 4-year growth in Operations Investment 2.7x 4-year growth in R&D investment S&M Operations R&D clearwateranalytics.com • 8 clearwateranalytics.com • 8 2019 2023
Slide 64: Delighting Our Clients
Delighting Our Clients Growth becomes easier – and more efficient Clearwater’s differentiated client success Legacy competitors Providers that rely largely on outdated technology and significant manual effort ~80% 60+ Competitive win Net Promoter 1 rate 2 Score 1 Based on deals over the past four ye
Slide 65: Trusted by Top Tier Institutions Globally
Trusted by Top Tier Institutions Globally
Slide 66: Efficient Growth: Gross Margin
But Growth At All Cost Is Not Productive Efficient Growth: One Measure is Gross Margin* $281.8 76.5% $253.8 $228.0 Unit economics matter 75.1% 78% $190.6 Measure of platform value, 75.6% operational efficiency and $152.7 $122.7 75.1% ultimately client value 73.1% 2019 2020 2021 2022 2023 2024 11 to
Slide 67: Adjusted EBITDA
$142.5* Adjusted EBITDA* 32% Q3 2024 EBITDA was $105.9 29% 33% $104.0 32% $81.1 27% $72.7 29% While increasing R&D $100 $57.1 27% 28% $50.8 from 22% in 2019 to 26% 30% in 2023 2019 2020 2021 2022 2023 2024 to Q3 YTD 12 $ in millions *Previously provided *Non-GAAP Q4 Guidance
Slide 68: Driving Acquisitions to Build a Front-to-Back Platform
Driving Acquisitions to Build a Market-Leading Front-to-Back Platform Wilshire JUMP Acquired an Acquired an Deployed an R&D Deployed a R&D team of 60 R&D team of 12 team of 90 by team of 50 by employees employees end of 2024 the end of 2024 In Sept 2022 In Q2 2024
Slide 69: Better Together
Better Together
Slide 70: Overall Strategic Rationale
Overall Strategic Rationale Today’s announcement is about creating a future where our clients benefit from the synergy of two highly complementary, innovative software leaders, paving the way for a unified, cloud-native front-to-back platform We expect this combination to do the following: 1. Accele
Slide 71: Front-to-Back platform for the entire investment lifecycle
Accelerate our goal of building a Front-to-Back platform for the entire 1 investment lifecycle Middle & Back Office Front Office Platform Front-to-back platform for the entire investment lifecycle At Market Above Market 16 Limited Capability No Capability
Slide 72: Expansion into the Asset Management industry
Expansion into the Asset Management industry 2 $4 B out of the current Core TAM of $5.9 B in Asset Management 17
Slide 73: Offer Enfusion's IBOR / PMS / OMS to Clearwater clients
Offer Enfusion’s IBOR/ PMS / OMS 3 to Clearwater clients Solutions Clearwater doesn’t fully address include: 1. Order Management 2. Portfolio Management 3. Pre-Trade risk and compliance 4. Front end of LPs 5. Mortgages 18
Slide 74: Leadership position in the Hedge Fund industry
Build on Enfusion’s leadership position in the Hedge Fund industry, 4 where Clearwater does not participate today $7.8bn $1.9bn $5.9bn $4.0bn $4.0bn The addition of Hedge Fund industry increases CWAN’s core TAM by $1.9bn Hedge Fund Asset Managers $1.6bn $1.6bn Insurance Corporations $0.3bn $0.3bn 19
Slide 75: Presence in Europe and Asia
Use Enfusion’s greater presence in Europe and Asia to drive faster 5 adoption of the CWAN platform 18% ~50% of our TAM is in Europe and 38% Asia and we currently derive only 18% of our revenue from those ENFN CWAN geographies 62% 82% % Revenue from United States Rest of World 20
Slide 76: Revolutionize?
Revolutionize? When an Asset Owner comes on our platform, we typically have 100% of their Global On One On One Using One Ingesting Assets on our platform Platform Instance Security Data Once Master because we are their Accounting Book of Record No one else has a globally comprehensive view of client
Slide 77: Outstanding and Engaged Team
Outstanding and Engaged Team 22
Slide 78: Employee Satisfaction Over Time
Employee Satisfaction Over Time: Anonymous Surveys ESS Score 10 9 8 7.6 7.5 7.5 7.4 7.4 7.3 7.3 7.2 7 Tech 6.7 Benchmark 6 5 4 91% Spring 2021 Fall 2021 Spring 2022 Fall 2022 Spring 2023 Fall 2023 Spring 2024 Fall 2024 Global Participation ESS Score Rate clearwateranalytics.com • 23 23
Slide 79: What We Stand For – Our Seven CW Attributes
What We Stand For – Our Seven CW Attributes Infectiously passionate about what we do 1 Intensely committed to our clients 2 Committed to building an outstanding, engaged team 3 Focused on execution – we get things done 4 Continuous innovation and improvement 5 Building truly differentiated offerings
Slide 80: Global Team and Footprint
Global Team and Footprint to Address All Client Needs Luxembourg ete (washington,0.c. } De. ae Hong Kong N —_— Total employees at 023: 1,756
Slide 81: Our Management Team
Our Management Team Sandeep Sahai Shane Akeroyd Cindy Blendu Jim Cox Souvik Das Sunil Dixit Scott Erickson Chief Executive Chief Strategy CHRO / Chief Transformation Chief Financial Chief Technology Chief Product Chief Revenue Officer Officer Officer Officer Officer Officer Officer Emmanuel Fougeras
Slide 82: Next Steps
Next Steps 1 3 4 2 Continue the deal Actively manage the Deal close and FAQs and improve our process through close – reactions from clients & integration begins understanding of each but we remain two partners other via joint separate companies integration planning until then teams This should be a
Slide 83: Q&A
Q&A CLEARWATER ANALYTICS.